Regulations.gov document
Pediatric Studies of Lorazepam; Establishment of Public Docket
Notice · FDA-2015-N-3037 · posted Mar 29, 2016
Key facts
| Document ID | FDA-2015-N-3037-0079 |
|---|---|
| Title | Pediatric Studies of Lorazepam; Establishment of Public Docket |
| Document type | Notice |
| Subtype | General Notice |
| Agency | FDA |
| Docket | FDA-2015-N-3037 |
| Posted | Mar 29, 2016 |
| Federal Register citation | 81 FR 17461 |
| FR document number | 2016-07012 |
| Comment period opens | Mar 29, 2016 |
| Comments due | Apr 29, 2016 |
| Effective date | Mar 29, 2016 |
At a glance
- 1–9 Pages
- No Open for comment
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: